He said the didn’t do that before now. I wonder if the fda told them about the overlap and wanted some data using the overlap? Definitely in the mono pivotal trial, but yes, it would make no sense to continue without the overlap once they realized that was an issue.

I’ve seen them not update the changes to the much mono trial, so it does not surprise me if the was not included.